43
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Use of an Isolated Joint Model to Detect Early Changes Induced by Intra-Articular Injection of Paclitaxel-Impregnated Polymeric Microspheres

, , , &
Pages 169-182 | Published online: 09 Jul 2009

References

  • Bitton RJ, Figg WD, Reed E. A preliminary risk-beneft as- sessment of paclitaxel. Drug Safety. 1995;12:196 –208.
  • Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H, Wilson L. Mitotic block induced in HeLa cells in low con- centrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res. 1996;56:816– 825.
  • Burt HM, Jackson JK, Bains SK, Liggins RT, Oktaba Am, Arsenault AL, Hunter WL. Controlled delivery of taxol from microspheres composed of a blend of ethylene–vinyl ac- etate copolymer and poly (d, l -lactic acid). Cancer Lett. 1995;88:73–79.
  • Brahn E, Tang C, Banquerigo ML. Regression of collagen- induced arthritis with taxol, a microtubule stabilizer. Arthritis Rheum. 1994;37:839 –845.
  • Oliver SJ, Banquerigo ML, Brahn E. Suppression of collagen-induced arthritis using an angiogenesis inhibitor, AGM-1470, and a microtubule stabilizer, taxol. Cell Im- munol. 1994;157:291 –299.
  • Arsesnault AL, Lhotak S, Hunter WL, Banquerigo ML, Brahn E. Taxol involution of collagen-induced arthritis: Ultrastructural correlation with the inhibition of synovi- tis and neovascularization. Clin Immunol Immunopathol. 1998;86:280–289.
  • Physicians Desk Reference. Oradell, NJ: 1999:714–717.
  • Bicher A, Levenback C, Burke TW, Morris M, Warner D, DeJesus Y, Gershenson DM. Infusion site soft-tissue in- jury after paclitaxel administration. Cancer. 1995;78:116– 120.
  • Wallis WJ, Simkin PA. Antirheumatic drug concentrations in human synovial fluid and synovial tissue; Observations on extravascular pharmacokinetics. Clin Pharmacokinet. 1983;8:496–522.
  • Mapp PI, Stevens CR, Blake DR. The physiology of the joint and its disturbance in inflammation. In Madison DJ ed. Oxford Textbook of Rheumatolog y. New York: Oxford University. Press; 1993.
  • Dordunoo SK, Jackson JK, Arsenault LA. Taxol encapsu- lation in poly(epsilon-caprolactone) microspheres. Cancer Chemother Pharmacol. 1995;36:279 –282.
  • Tarr BD, Sambanda n TG, Yalkowsky SH. A new parenteral emulsion for the administration of taxol. Pharmaceut Res. 1987;4:162–165
  • Greenwald RB, Gilbert CW, Pendri A, Conover CD, Xia J, Martinez A. Drug delivery systems: water soluble taxol 2’- poly(ethylene glycol) ester prodrugs—Design and in vivo effectiveness. J Med Chem. 1996;39:424 –431.
  • Sharma A, Mayhew E, Straubinger RM. Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model. Cancer Res. 1993;53:5877 –5881.
  • Adkins D. J Exp Phys Cognate Med Sci. 1939;30:147 –154.
  • Ratcliffe JH, Hunneyball IM, Wilson CG, Smith A, Davis SS. Albumin microspheres for intra-articular drug delivery: in- vestigation of their retention in normal and arthritic knee joints of rabbits. J Pharm Pharmacol. 1987;39:290 –295.
  • Ratcliffe JH, Hunneyball IM, Smith A, Wilson CG, Davis SS. Preparation and evaluation of biodegradabl e polymeric systems for the intra-articular delivery of drugs. J Pharm Pharmacol. 1984;36:431 –436.
  • Visscher GE, Robinson RL, Maulding HV, Fong JW, Pear- son JE, Argentieri GJ. Biodegradation of and tissue reac- tion to 50:50 poly(DL-lactide-co-glycolide) microcapsules. J Biomed Mater Res. 1985;19:349 –365.
  • Weig G, Kotoura Y, Oda M, et al. A bioabsorbabl e drug delivery system for antibiotic treatment of osteomyelitis. J Bone Joint Surg. 1991;73:246 –252.
  • Bertone AL, Hardy J, Simmons EJ, Muir WW 3rd. Vascular and transsynovial forces of the isolated stationary equine joint. Am J Vet Res. 1998;59:495 –503.
  • Hardy J, Bertone A, Muir WW 3rd. Local hemodynam- ics, permeability, and oxygen metabolism during acute inflammation of innervated or denervated isolated equine joints. Am J Vet Res. 1998;59:10.
  • Allen D Jr, Clark ES, Moore JN, Prasse KW. Evaluation of equine digital starling forces and hemodynamics during early laminitis. Am J Vet Res. 1990;51:1930 –1934.
  • Mankin HJ, Dorfman H, Zarins A, Lippiello L. Biochemi- cal and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. J Bone Joint Surg. 1971;53A: 523.
  • Farndale RW, Sayers CA, Barrett AJ. A direct spectropho- tometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connec Tissue Res. 1982;9:247–248.
  • Palmer JL, Bertone AL, McClain H. Assessment of glycosa- minoglycan concentration in equine synovial fluid as a marker of joint disease. Can J Vet Res. 1995;59:205 –212.
  • Nade S, Newbould PJ. Pressure–volume relationships and elastance in the knee joint of the dog. J Physiol. 1984;357:417 –439.
  • Knight AD, Levick JR. Pressure-volume relationships above and below atmospheric pressure in the synovial cavity of the rabbit knee. J Physiol. 1983;335:139 –152.
  • Levick, JR. Absorption of artifcial effusions from syn- ovial joints: An experimental study in rabbits. Clin Sci. 1980;59:41–48.
  • Knight AD, Levick JR. The influence of blood pressure on trans-synovial flow in the rabbit. J Physiol. 1984;349:27– 42.
  • Levick JR. Contributions of the lymphtic and microvascular systems to fluid absorption from the synovial cavity of the rabbit knee. J Physiol. 1980;306:445 –461.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.